John A. Roberts - 24 Nov 2021 Form 4 Insider Report for Vyant Bio, Inc.

Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
24 Nov 2021
Net transactions value
+$10,100
Form type
4
Filing time
24 Nov 2021, 15:05:24 UTC
Previous filing
25 Aug 2021
Next filing
17 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $10,100 +5,000 +14% $2.02 39,807 24 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.